Adjustable Height Needle Infusion Device

ABSTRACT

An infusion set has a retraction dial that can be removably assembled with the infusion set and access a threaded needle hub contained therein such that the dial can be used to advance or retract a needle hub and an inserted needle to a more precisely controlled insertion depth to deliver insulin or other medicament intradermally (i.e. to the upper 3 mm of skin surface). Position of the inserted needle can be maintained by providing a separated and isolated needle hub, main base and main hub of the infusion set that can isolate the inserted needle from external forces such that the needle can be maintained at a depth to deliver content to the upper 3 mm of skin surface during normal use.

CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a division of a U.S. patent application of RyanSchoonmaker et al. entitled “Adjustable Height Needle Infusion Device”,Ser. No. 13/303,055, filed November 22, 2011, which claims the benefitunder 35 U.S.C. §119(e) of a U.S. provisional patent application of RyanSchoonmaker et al. entitled “Adjustable Height Needle Infusion Device”,Ser. No. 61/344,971, filed on Nov. 30, 2010, the entire content of bothof said prior applications being incorporated herein by reference,

FIELD OF THE INVENTION

The present invention relates generally to components and elements ofinfusion sets, including a retraction dial for an infusion set, whichensures proper positioning of needle insertion by removably couplingwith an infusion set and allowing a user to adjust a final needle depthby turning the dial.

BACKGROUND OF THE INVENTION

A large number of people, including those suffering from conditions suchas diabetes use some form of infusion therapy, such as daily insulininfusions to maintain close control of their glucose levels. There aretwo principal modes of daily insulin. therapy. The first mode includessyringes and insulin pens. These devices are simple to use and arerelatively low in cost, but they require a needle stick at eachinjection, typically three to four times per day. The second modeincludes infusion pump therapy, which entails the purchase of an insulinpump that lasts for about three years. The initial cost of the pump canbe significant, but from a user perspective, the overwhelming majorityof patients Who have used pumps prefer to remain with pumps for the restof their lives. This is because infusion pumps, although more complexthan syringes and pens, offer the advantages of continuous infusion ofinsulin, precision dosing and programmable delivery schedules. Thisresults in closer blood glucose control and an improved feeling ofwellness.

The use of an infusion pump requires the use of a disposable component,typically referred to as an infusion set or pump set, which conveys theinsulin from a reservoir within the pump into the skin of the user. Aninfusion set typically consists of a pump connector, a length of tubing,and a hub or base from which an infusion needle or cannula extends. Thehub or base has an adhesive which retains the base on the skin surfaceduring use, and may be applied to the skin manually or with the aid of amanual or automatic insertion device.

Currently, most insulin infusion sets deliver insulin to thesub-cutaneous layers of skin using either fixed metal needles orflexible plastic cannulas. Such infusion sets typically deliver insulin4-10 mm below the skin surface. However, the upper 3 mm of skin surface,the intradermal space, facilitates better drug absorption.Unfortunately, due to the, relative, thinness of the intradermal layer,inserting a needle at such depth and maintaining an infusion site overan extended period of time within this narrow band is difficult.

Further, most insulin infusion sets typically do not provide anyfeatures to isolate the inserted needle from shock or other externalforces. Since these infusion sets typically deliver insulin 4-10 mmbelow the skin surface, shock or other external forces to the set haveless effect on the deeper inserted needle. However, where an attempt ismade to target the upper 3 mm of skin surface, any shock or movement ofthe set can adversely affect needle insertion and infusion performance.

Still further, most insulin sets have inserters that can result in skinsurface “tenting” during needle insertion, where the skin surface isdeflected somewhat prior to or during needle insertion, which makesprecisely targeting the upper 3 mm of skin surface difficult.

Accordingly, a need exists for advanced, improved, and novel componentsand elements of current and future infusion sets that can delivercontent to the upper 3 mm of skin surface, the intradermal space, tofacilitate better drug absorption, while maintaining a degree of comfortto the user.

SUMMARY OF THE INVENTION

An object of the present invention is to provide an infusion set whichcan deliver insulin or other medicament to the upper 3 mm of skinsurface, the intradermal space, to facilitate better drug absorption,while maintaining a degree of comfort to the user.

Another object of the present invention is to provide an infusion sethaving an inserter that can insert a needle which can be removed fromthe infusion set after insertion.

Another object of the present invention is to provide an infusion setwith a removable retraction dial on its upper surface, wherein theretraction dial can be used to precisely retract an inserted needle toreach a desired depth to deliver insulin or other medicament to theupper 3 mm of skin surface, or retract an inserter needle some distanceinto a soft cannula after insertion.

Another object of the present invention is to provide an infusion setthat includes a needle hub in a threaded engagement with a main base,such that rotation of the needle hub relative to the main base resultsin retraction or advancement of a needle of the needle hub.

Another object of the present invention is to provide an infusion setwith the removable retraction dial to rotate the needle hub relative tothe main base to precisely retract an inserted needle to reach a desireddepth to deliver insulin or other medicament to the upper 3 mm of skinsurface.

Another object of the present invention is to provide an infusion setthat can isolate an inserted needle from external forces such that theneedle can he maintained at a depth to deliver insulin or othermedicament to the upper 3 mm of skin surface during normal use.

These and other objects are substantially achieved by providing aninfusion set having a retraction dial that can be removably assembledwith the infusion set and access a threaded needle hub contained thereinsuch that the dial can be used to advance or retract an inserted needleto a depth to deliver insulin or other medicament to the upper 3 mm ofskin surface, or retract an inserter needle some distance into a softcannula after insertion. Position of the inserted needle can bemaintained by providing a needle hub, main base and main hub of theinfusion set that can isolate the inserted needle from external forcessuch that the needle can be maintained at a depth to deliver insulin orother medicament to the upper 3 mm of skin surface during normal use.

BRIEF DESCRIPTION OF THE DRAWINGS

The various objects, advantages and novel features of the exemplaryembodiments of the present invention will be more readily appreciatedfrom the following detailed description when read in conjunction withthe appended drawings, in which:

FIG. 1 is a perspective view of an infusion set in accordance with anembodiment of the present invention;

FIG. 2 is a bottom perspective view of the infusion set of FIG. 1;

FIG. 3 is a cross-sectional view of the infusion set of FIG. 1 showingthe needle in an inserted position, but prior to user retraction, inaccordance with an embodiment of the present invention;

FIG. 4 is a bottom perspective view of the infusion set of FIG. 1 shownwithout an adhesive layer for illustrative purposes in accordance withan embodiment of the present invention;

FIG. 5 is a top perspective view of the infusion set of FIG. 1 with theretraction dial removed in accordance with an embodiment of the presentinvention;

FIG. 6 is a bottom perspective view of the infusion set of FIG. 1illustrating a soft cannula insertion in accordance with an embodimentof the present invention; and

FIG. 7 is a top perspective view of the infusion set of FIG. 1 with theretraction dial removed and the infusion pump tube connection in placein accordance with an embodiment of the present invention.

Throughout the drawings, like reference numerals will be understood torefer to like parts, components and structures.

DETAILED DESCRIPTION OF THE EXEMPLARY EMBODIMENTS

The exemplary embodiments of the present invention described belowprovide a novel means of delivering insulin to the intradermal layers ofskin via a standard insulin pump. In particular, the exemplaryembodiments of the present invention provide an infusion set with aretraction dial to advance or retract an inserted needle to deliverinsulin to the upper 3 mm of skin surface, the intradermal space, tofacilitate better drug absorption, while maintaining a degree of comfortto the user.

As will be appreciated by one skilled in the art, there are numerousways of carrying out the examples, improvements and arrangements ofinsulin-associated devices disclosed herein. Although reference will bemade to the exemplary embodiments depicted in the drawings and thefollowing description, the embodiments disclosed herein are not meant tohe exhaustive of the various alternative designs and embodiments thatare encompassed by the disclosed invention.

As noted, the exemplary embodiments of the present invention deliverinsulin to the intradermal layers of the skin via a standard insulinpump or other similar device. By utilizing a refraction dial, and anisolated needle hub, proper insertion and maintenance of the insertedneedle in the intradermal space is ensured. Position of the insertedneedle can be maintained by providing a needle hub, main base and mainhub of the infusion set, and tube attachment, that can isolate theinserted needle from external forces such that the desired needle depthcan be maintained.

Proper needle insertion stands as a primary obstacle to infusing insulinvia a pump into the intradermal layer. In the exemplary embodiments ofthe present invention, the initial insertion of the needle issubstantially the same as performed using any standard infusion set, buta removable retraction dial is provided to advance or retract theinserted needle, or retract an inserter needle some distance into a softcannula after insertion. By retracting the inserted needle a slightdistance, medicament can be delivered into the thin intradermal layer.Utilizing precision parts, this process can be reliable when compared toa standard manual intradermal injection procedure, such as the Mantouxtechnique.

However, maintaining the position of the needle within the intradermallayers of the skin over the course of a typical three-day period posessignificant technical challenges. Accordingly, the exemplary embodimentsof the present invention further provide at least two methods ofanchoring the needle in place. First, the main base of the devicecreates and maintains a preload on the skin surface, which locks theneedle in place vertically. Second, an adhesive may be applied to themain base in the area of the needle, locking the skin surface to theneedle location.

FIGS. 1 and 2 are perspective views of an infusion. set in accordancewith an embodiment of the present invention. As shown in FIGS. 1-3, theexemplary infusion set 10 can comprise an outer hub 12, main hub 14,main base 16, needle hub 18, and retraction dial 20. An outer ring 22rotatably extends between the outer hub 12 and retraction dial 20. Thehub, base and other elements can be constructed of a molded plasticmaterial, polycarbonate, thermoplastic polymer such as polyethyleneterephthalate (PET and PETG), or similar materials.

As shown in greater detail in FIGS. 2 and 3, the needle hub 18 ispositioned within the main base 16, and comprises a needle 24. The mainbase 16 contains the needle hub 18 and an optional needle hub adhesivelayer 26. A main base inner adhesive layer 28 can also be provided onthe main base 16, and an outer hub adhesive layer 30 can be provided onthe outer hub 12.

The needle hub 18 is held within an opening of the main base 16 via ahelical threaded engagement between the needle hub 18 and the main base16. A female thread groove 17 in the wall of opening 38 receives a malethread 19 on the needle hub 18. In doing so, rotation of the needle hub18 within the opening 38 of the main base 16 serves to advance orretract the needle hub 18 via the threaded engagement, within theopening 38 of the main base 16, thereby advancing or retracting theneedle 24 relative to the main base 16 adhered to the skin surface.

The main hub 14 rotatably covers the main base 16 and provides a fluidcommunication channel 52 between an inner septum 32 and a valveconnection septum 34. The main hub 14 is held in place by the flexibletube connection 48 between the main hub 14 and the outer ring 22, asshown in FIG. 4, and by the geometry of the main base 16 and the outerring 22. As illustrated in FIG. 3, the needle 24 comprises first andsecond ends, wherein the first end is configured to penetrate a skinsurface (not shown), and the second end (which may be sharpened orunsharpened) is configured to penetrate an inner septum 32 (which may bepre-slit and/or pierceable) as described in greater detail below. Theinner septum 32 is held within a protrusion 36 of the main hub 14, whichis configured to slidably engage a similarly shaped opening 54 in theneedle hub 18 as the needle hub is advanced or retracted. The needle 24can comprise a 31 gauge, 3 mm in length, single-bevel stainless steelneedle/cannula, but is not limited thereto. In other embodiments of thepresent invention, the needle 24 can be plastic or other material,between 27 gauge and 34 gauge, between 2 mm and 5 mm in length, and beprovided with a tri-bevel or 5-bevel needle. The needle 24 can be bondedto the needle hub 18 with an adhesive, such as a Loctite/UV curedadhesive, or can be over molded with, or threaded into, the needle hub.Further, other embodiments of the present invention, the needle 24 canbe replaced with a soft cannula provided with an internal introducerneedle that can be retracted inside the soft cannula. The needle 24 canalso comprise a needle longer than that used to simply target theintradermal layer, since the needle of the exemplary embodiments of thepresent invention is first inserted to a depth of, for example, 5 mm to6 mm, and then retracted to the targeted intradermal depth of forexample, 3 mm or less, As described in greater detail below, this allowsuse of a longer needle, minimizes the risk of tenting or skin deflectionaffecting the final insertion depth, and creates an opening to minimizepressure.

The example shown in FIG. 3 illustrates an infusion set wherein theneedle 24 has been inserted (or, in the case of a soft cannula andinternal introducer needle, wherein the soft cannula and introducerneedle have been inserted), and the retraction dial 20 exposed. Theretraction dial 20 comprises at least one member 40 extending through anopening 56 of the main hub 14 and terminating in an opening 58 of theneedle hub 18 to transmit a rotary force thereto.

The retraction dial 20 is configured to cover the main hub 14 and mainbase 16 to permit user adjustment of the needle 24 depth. To do so, theretraction dial 20 comprises the least one member 40 extending throughthe opening 56 of the main hub 14 and terminating in the opening 58 ofthe needle hub 18. Accordingly, when the retraction dial 20 and member40 are turned, the main hub 14 and needle hub 18 are turned with theretraction dial 20. However, the main base 16 remains stationary, inadhesive contact with the skin surface. Accordingly, as the needle hub18 is rotated by the member 40, the threaded engagement with thestationary main base 16 results in an upward or downward movement of theneedle hub 18 and the attached needle 24 (or, in the case of a softcannula and internal introducer needle, results in the introducer needlebeing retracted or advanced inside the soft cannula).

Accordingly, by turning the retraction dial 20, a user can retract(i.e., move upward) the needle 24. In doing so, a desired depth ofneedle penetration can be achieved more precisely. Further, thepassageway initially created by the fully inserted needle, results in anopening or unfilled passageway as the needle 24 is slightly retracted.The benefits associated with infusion to this additional unfilledpassageway are described below. Still further, as the needle 24 isretracted, the second end of the needle 24 contacts and pierces theinner septum 32, such that the needle 24 is in fluid communication withthe channel 52 of the main hub 14.

The retraction dial 20 is further configured to simply pull free fromthe main hub 14 and main base 16 after the desired retraction, as themember 40 is simply held in place by friction engagement with thethrough-openings 56 and 58, and the opening 60 between the main hub 14and outer ring 22. Accordingly, upon reaching the desired retractiondepth, which can be denoted by a positive stop or some otheruser-detectable feature, the retraction dial 20 can be removed, therebyleaving the device as shown in FIG. 5. The retraction dial 20 can bemarked to denote needle depth, or can be configured to release from theinfusion set when the needle reaches a desired depth (i.e. about onerotation or 360 degrees). Still further, it may be desirable to retainthe retraction dial 20 in place for later needle height adjustments. Byallowing the user to make minute adjustments to the needle height withinthe intradermal layer, tissue tolerance of infusion may increase. Also,occlusions caused by foreign body response at the end of the needle maybe released by these movements. Such a height adjustment feature is easyto adjust in small increments, yet difficult to move accidentally. Arelease button (not shown) can also be provided. it can also be possibleto allow the user to selectively adjust the height to either asubcutaneous or intradermal height setting.

In yet another exemplary embodiment of the present invention shown inFIG. 6, an internal introducer needle 124 can be used to insert a softcannula 126, and then be partially retracted or withdrawn a distanceinto the cannula using the retraction dial 20. In this case, theretraction dial 20 can be used to control a distance the introducerneedle is withdrawn into the cannula, and subsequently, to control thelength of flexible cannula free of the introducer needle. For example,the device can be used to insert the soft cannula 126 and the retractiondial 20 can be used to retract or withdraw the introducer needle 124some distance back into the soft cannula. The soft cannula can compriseTeflon or Vialon, and be between 25 gauge and 32 gauge. In such anexemplary embodiment, a steel introducer needle can be provided and bebetween 27 gauge and 34 gauge for proper fitting inside the softcannula.

At this time, the infusion pump tube attachment 42 and tubing 44 to theinfusion pump (not shown) can be attached to the top of the infusion setas shown in FIG. 7. FIG. 7 is a top perspective view of the infusion setof FIG. 1 with the retraction dial removed and the infusion pump tubeconnection in place. The infusion pump tube attachment 42 comprises acircular cover piece to which the tubing 44 is attached and routedthrough to a septum piercing member (not shown) to engage and pierce thevalve connection septum 34. Alignment between the infusion pump tubeattachment 42 and the valve connection septum 34 is achieved through theengagement with the self-alignment features, or slots, 46 in the outerring 22. For example, an inner surface of the cover piece of theinfusion pump tube attachment 42 can comprise one or more projections orboss features (not shown) which mate with the slots 46 to thereby allowcomplete downward assembly of the infusion pump tube attachment 42 withthe infusion set when the valve connection septum 34 is in alignment forpiercing.

In addition, the infusion pump tube attachment 42 is free to rotate 360degrees, allowing the tubing 44 to the pump to be arranged in acomfortable orientation. To do so, the outer ring 22 to which the tubeattachment 42 is secured, is rotatable between the outer hub 12 and themain hub 14. Specifically, the outer ring 22 of the device is configuredto be rotatable along track-like features 62 in the outer hub 12, whichis fixed to the user's skin surface. By connecting the outer hub 12 andthe outer ring 22 via the track features 62, and connecting the outerring 22 to the main hub 14 via the thin flexible length of tubing 48,the outer ring 22 and valve connection septum 34 can rotate as permittedby the flexible tubing 48, In doing so, the infusion pump tubeattachment 42 is permitted to rotate. In the exemplary embodiment shown,the flexible tubing 48 at least partially encircles the main hub 14 andmain base 16, which permits a shorter or flatter device profile.

Vibrational and shock isolation of the main hub 14 and main base 16,from the outer hub 12, outer ring 22 and valve connection septum 34, isachieved in a number of ways, including the provision of the trackfeatures 62 between the outer hub 12 and the outer ring 22, and theflexible tubing 48 between the fluid channel 52 of the main hub 14 andconnection valve 50 of the outer ring 22. Further, once the retractiondial 20 is removed, the main hub 14 and main base 16 are separated fromthe outer hub 12 and outer ring 22. That is, first, the main hub 14 andthe outer ring 22 are physically separated and are connected only by theflexible tubing 48, and second, the main hub 14 and main base 16 aresecured to the skin surface via adhesive layers 26 and 28, and the outerhub 12 is secured to the skin surface via adhesive layer 30, wherein thelayers 26, 28 and 30 are physically separated. In doing so, the onlyconnection between the main hub 14 and main base 16, and the outer hub12 and outer ring 22 (and the attached infusion pump tube attachment42), is the flexible tubing 48. Further, once covered by the tubeattachment described in greater detail below, external contact with themain hub 14 and main base 16 is prevented.

The exemplary embodiments of the present invention provide a novel meansof delivering insulin to the intradermal layers of skin via standardinsulin pumps, but are not limited thereto. The invention can also beapplied to patch pumps or other infusion devices.

Further, the exemplary embodiments comprise a straight microneedle,needle, or other cannula, that can be inserted by the user into thedeeper dermis or the subcutaneous layers of the skin, and can then bewithdrawn with a great deal of precision into the dermal layer, where itis held by adhesive and/or mechanical preload.

Initial insertion of the infusion set with a user controllable needledepth is similar to the operation of fixed steel cannula devicescurrently on the market. The user first peels off a flexible backing,removes a needle cover, and then inserts the needle into the infusionsite. After ensuring good skin adhesion, the user then turns theretraction dial. The retraction dial can be marked to denote needledepth, reach a positive stop, or can be configured to release from theinfusion set when the needle reaches a desired depth (i.e. about onerotation or 360 degrees). In an exemplary embodiment, the retractiondial is configured to turn a quarter turn (i.e., 90 degrees) to reachthe desired depth. The user can then remove the retraction dial andattach the pump tube attachment, in the case of an infusion set, fromthe top of the device. The device is then ready to prime and deliverinsulin. In addition, the valve connection is free to rotate up to 360degrees, allowing the tubing to the pump to be arranged in a comfortableorientation.

As the retraction dial 20 turns, the needle 24 and needle -hub 18 of thedevice move up the threaded engagement 17 and 19 located in the mainbase 16. The needle 24 protrudes from both sides of the needle hub 18and, on the side opposite the side that pierces the skin, the needle 24pierces through the inner septum 32 as it moves upward, establishingfluid communication with the valve connection interface. As the needle24 pierces the inner septum 32 in such a manner, it can be locked inplace with respect to the main base 16. To do so, a detent or projectionnot shown) can be provided on an outer surface of the needle hub 18 thatis configured to mate with a similar detent or projection (not shown)provided on an inner surface of the main base 16 when the needle hub 18reaches the desired position. Once engaged, the detents can lock theneedle hub 18 in place with the main base 16. The fluid path 30 is openthrough the main hub 14 and the flexible piece of tubing 48 which leadsto the valve connection septum 34 located in the outer ring 22, which isable to rotate about the main hub 14 and main base 16 as permitted bythe track in the outer hub 12 and tubing 48.

As shown in FIG. 3, the main base 16 also provides a contour on a lowersurface that contacts the skin surface around the needle 24, providing aslight preload, or indentation, on the skin surface which helps maintainthe needle position within the intradermal layer. In addition, adhesivelayer 26 can be placed on the main base 16 in the vicinity of the needle24 to help with the anchoring of the needle in the skin surface.

The outer ring 22 of the device is configured to be rotatable along thetrack-like features 62 in the outer hub 12, which is fixed to the user'sskin surface. By connecting the outer hub 12 and the outer ring 22, tothe main hub 14 and main base 16, via the thin flexible length of tubing48, external forces and vibrations are absorbed by the outer hub 12 andthe outer ring 22, but not by the main hub 14, main base 16, needle hub18 and the needle 24. Finally, the infusion pump tube attachment 42 canbe attached to the outer ring 22, covering the assembly and providingfurther isolation of the needle, and the self-centering features ofslots 46 ensure that the valve connection needle (not shown) pierces thevalve connection septum 34.

As noted above, the passageway initially created by the fully insertedneedle, results in an opening or unfilled passageway as the needle 24 isslightly retracted. As known in the art, high pumping pressure (i.e.,20-50 or more psi), can occur during intradermal infusion. However, byfirst providing the deeper insertion tunnel established by the initialinsertion depth as recited above, and the subsequent withdrawal to theinfradermal layer, embodiments of the present invention can relieve suchpressures by increasing the surface area of the deposition area.

Further, by infusing into the intradermal layer of the skin, theexemplary embodiments of the present invention offer the potential forbetter absorption of insulin when compared to subcutaneous deliverysystems. In doing so, it may be possible for the typical user to bothconsume less insulin and maintain a better medicament regime.

Other intradermal infusion set concepts are at risk of “tenting”, whichis the undesired effect where skin is deflected at needle insertionbefore or during insertion, creating a shape similar to a tent. In doingso, the skin surface tents during needle insertion rather than needlepenetration into the skin. However, since a longer needle can be used,and then slightly retracted in the exemplary embodiments of the presentinvention, the risk of tenting or skin deflection otherwise affectingfinal insertion depth is reduced. Still further, a small intradermalneedle placed perpendicular to the skin and isolated from outside forcescauses less pain to the user during use.

In current steel cannula, infusion sets which deliver to thesubcutaneous layer, the needle is not isolated from any undesiredoutside forces which may cause pain when translated to the needle andthe needle moves within the skin. Also, other intradermal devices faceproblems of premature or otherwise undesired needle removal when thedevice is bumped, if the needle is not isolated from the outside forces.

In the exemplary embodiments of the present invention, the intradermalneedle is isolated from outside forces by a cover design, a double ringfeature, and the provision of flexible tubing. Such features help toeffectively isolate the needle from the outside forces and otherinterferences.

By infusing into the intradermal layer of the skin, the exemplaryembodiments of the present invention offer the potential for betterabsorption of the insulin when compared to subcutaneous deliverysystems. It may be possible for the user to maintain a better medicamentregimen while using less insulin. Further, the provision of a smallintradermal needle placed perpendicular to the skin and isolated fromoutside forces causes less pain and discomfort to the user during use.

Although only a few exemplary embodiments of the present invention havebeen described in detail above, those skilled in the art will readilyappreciate that many modifications are possible in the exemplaryembodiments without materially departing from the novel teachings andadvantages of this invention. Accordingly, all such modifications areintended to be included within the scope of this invention as defined inthe appended claims and their equivalents.

What is claimed is:
 1. A method for targeting a desired depth to delivercontent to an upper skin surface, comprising the steps of: placing aninfusion set upon an infusion site such that an infusion needle isinserted; moving said infusion needle until a desired infusion depth isreached; and attaching an infusion pump tube attachment.
 2. A method fortargeting a desired depth as claimed in claim 1, further comprising thestep of turning a refraction dial, releasably coupled with said infusionset, wherein said retraction dial is configured to rotate relative tosaid infusion set and wherein said rotation is translated into movementof said infusion needle.
 3. A method for targeting a desired depth asclaimed in claim 2, wherein said rotation of said retraction dial istranslated into vertical movement of said infusion needle.
 4. A methodfor targeting a desired depth as claimed in claim 2, further comprisingthe step of removing said retraction dial from said infusion set.
 5. Amethod to retract an introducer needle some distance into a soft cannulaafter insertion, comprising the steps of: placing an infusion set uponan infusion site such that an introducer needle and soft cannula areinserted; moving said introducer needle until said introducer needle isretracted a desired distance into said soft cannula; and attaching aninfusion pump tube attachment.
 6. A method to retract an introducerneedle as claimed in claim 5, further comprising the step of turning aretraction dial, releasably coupled with said infusion set, wherein saidrefraction dial is configured to rotate relative to said infusion setand wherein said rotation is translated into movement of said introducerneedle.
 7. A method to retract an introducer needle as claimed in claim6, wherein said rotation of said retraction dial is translated intovertical movement of said introducer needle
 8. A method to retract anintroducer needle as claimed in claim 6, further comprising the step ofremoving said retraction dial from said infusion set.
 9. A method fortargeting a desired depth to deliver content to an upper skin surface ata reduced pressure, comprising the steps of placing an infusion set uponan infusion site such that an infusion needle is inserted. to create anopening in said skin; moving said infusion needle to remove saidinfusion needle from a portion of said opening; and attaching aninfusion pump tube attachment and delivering content to at least saidportion of said opening, wherein said portion of said opening increasesa surface area of a deposition.
 10. A method for targeting a desireddepth to deliver content as claimed in claim 9, further comprising thestep of turning a. retraction dial, releasably coupled with saidinfusion set, wherein said retraction dial is configured to rotaterelative to said infusion set and wherein said rotation is translatedinto movement of said introducer needle.
 11. A method fur targeting adesired depth to deliver content as claimed in claim 10, wherein saidrotation of said retraction dial is translated into vertical movement ofsaid introducer needle
 12. A method for targeting a desired depth todeliver content as claimed in claim 10, further comprising the step ofremoving said retraction dial from said infusion set.